These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33004215)

  • 1. Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer.
    Nasioudis D; Albright BB; Roy A; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2020 Dec; 159(3):732-736. PubMed ID: 33004215
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States.
    Renz M; Diver E; English D; Kidd E; Dorigo O; Karam A
    J Minim Invasive Gynecol; 2020 Feb; 27(2):482-488. PubMed ID: 30980995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
    Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
    Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists.
    Chambers LM; Vargas R; Michener CM
    J Gynecol Oncol; 2019 May; 30(3):e35. PubMed ID: 30887757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma.
    Gómez-Hidalgo NR; Chen L; Hou JY; Tergas AI; St Clair CM; Ananth CV; Hershman DL; Wright JD
    Cancer Invest; 2018 Mar; 36(3):190-198. PubMed ID: 29565689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer.
    Albright BB; Nasioudis D; Byrne ME; Latif NA; Ko EM; Haggerty AF
    Gynecol Oncol; 2020 Dec; 159(3):758-766. PubMed ID: 32981697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer.
    Jou J; Charo L; Hom-Tedla M; Coakley K; Binder P; Saenz C; Eskander RN; McHale M; Plaxe S
    Gynecol Oncol; 2021 Nov; 163(2):299-304. PubMed ID: 34561099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
    Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
    Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?
    Bogani G; Raspagliesi F
    J Gynecol Oncol; 2019 May; 30(3):e68. PubMed ID: 30887766
    [No Abstract]   [Full Text] [Related]  

  • 16. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
    Alimena S; Fiascone S; Krasner C; King M; Horowitz N
    Curr Probl Cancer; 2019 Oct; 43(5):443-449. PubMed ID: 30770127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer.
    Tanaka T; Terai Y; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Yamamoto K; Yamada T; Ohmichi M
    Int J Clin Oncol; 2018 Apr; 23(2):305-313. PubMed ID: 29098518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.